The effects of provera on chemotherapy of uterine cancer cell lines
- 31 August 1991
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 42 (2), 165-177
- https://doi.org/10.1016/0090-8258(91)90339-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Comparative chemosensitivity profiles in four human ovarian carcinoma cell lines measuring ATP bioluminescenceGynecologic Oncology, 1990
- Synergistic effects of cis-platinum and cystosine arabinoside on ovarian carcinoma cell lines, demonstrated by dual-parameter flow cytometryGynecologic Oncology, 1989
- Application of an ATP-bioluminescence assay in human tumor chemosensitivity testingGynecologic Oncology, 1988
- Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometriumAmerican Journal of Obstetrics and Gynecology, 1988
- Steroid Receptors in Breast, Uterine, and Ovarian MalignancyPublished by Springer Nature ,1987
- Melphalan, 5-Fluorouracil, and Medroxyprogesterone Acetate in Metastatic Endometrial CarcinomaObstetrics & Gynecology, 1986
- Treatment of advanced or recurrent endometrial carcinoma with medroxyprogesterone acetate (MPA): A gynecologic oncology group studyGynecologic Oncology, 1985
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984
- Gestagens and endometrial carcinomaGynecologic Oncology, 1976
- The treatment of advanced endometrial cancer with hydroxyprogesterone caproateGynecologic Oncology, 1974